Author:
Zinzi Alessia,Gaio Mario,Liguori Valerio,Cagnotta Cecilia,Paolino Donatella,Paolisso Giuseppe,Castaldo Giuseppe,Nicoletti Giovanni Francesco,Rossi Francesco,Capuano Annalisa,Rafaniello Concetta
Reference50 articles.
1. The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors;Su;Pharmacol Res,2021
2. Motais, B.; Charvátová, S.; Hrdinka, M.; Šimíček, M.; Jelínek, T.; Ševčíková, T.; Kořístek, Z.; Hájek, R.; Bagó, J.R. A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers. Cancers (Basel). 2020, 12, doi:10.3390/cancers12051333.
3. Chimeric antigen receptor T-Cell therapy for the community oncologist;Maus;Oncologist,2016
4. CAR-T cell therapy: current limitations and potential strategies;Sterner;Blood Cancer J.,2021
5. CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?;Safarzadeh Kozani;Stem Cell Res. Ther.,2021
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献